Apollo Therapeutics

Recent Finacing

Series C

Recent Raise

$226.5M

Apollo Therapeutics is a biopharmaceutical company that translates medical research into medicines, with a focus on advancing pipeline programs through clinical development, drug discovery, and licensing or acquiring additional clinical stage programs.